![](https://endpts.com/wp-content/uploads/2022/11/Abigail-Jenkins-Gamida-Cell-CEO.jpg)
Abbey Jenkins, Gamida Cell CEO
Gamida Cell wins FDA approval for new cord blood-based therapy for cancer patients
The FDA on Monday approved Israel-based Gamida Cell’s Omisirge (omidubicel-onlv), an allogeneic cord blood-based cell therapy used to quicken the recovery of white blood cells …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.